Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.850
-0.110 (-2.78%)
Dec 3, 2024, 1:44 PM EST - Market open
Aclaris Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 275 | 74 | 1,050 | 890 | 278 | 78 | |
| Market Cap Growth | -83.08% | -92.92% | 17.97% | 220.59% | 254.99% | -74.14% | |
| Enterprise Value | 112 | -110 | 805 | 650 | 238 | 21 | |
| Last Close Price | 3.96 | 1.05 | 15.75 | 14.54 | 6.47 | 1.89 | |
| PS Ratio | 10.41 | 2.38 | 35.30 | 131.67 | 42.84 | 18.51 | |
| PB Ratio | 2.17 | 0.47 | 5.31 | 4.51 | 7.38 | 1.12 | |
| P/TBV Ratio | 0.63 | 0.47 | 5.51 | 4.68 | 9.10 | 1.25 | |
| EV/Sales Ratio | 4.12 | - | 27.04 | 96.09 | 36.79 | 5.02 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.38 | 0.06 | |
| Asset Turnover | 0.14 | 0.14 | 0.12 | 0.04 | 0.08 | 0.02 | |
| Quick Ratio | 6.81 | 3.86 | 9.94 | 8.37 | 3.69 | 3.30 | |
| Current Ratio | 7.03 | 4.16 | 10.55 | 8.94 | 3.87 | 3.74 | |
| Return on Equity (ROE) | -25.83% | -49.88% | -44.01% | -77.33% | -95.12% | -79.67% | |
| Return on Assets (ROA) | -19.39% | -32.53% | -21.04% | -25.38% | -35.87% | -30.70% | |
| Return on Capital (ROIC) | -26.72% | -40.78% | -26.60% | -32.43% | -48.17% | -35.95% | |
| Earnings Yield | -13.51% | -118.96% | -8.27% | -10.21% | -18.37% | -206.27% | |
| FCF Yield | -6.74% | -107.07% | -6.49% | -5.89% | -14.08% | -125.36% | |
| Buyback Yield / Dilution | -3.48% | -7.05% | -14.95% | -33.36% | -2.94% | -25.57% | |
| Total Shareholder Return | -3.48% | -7.05% | -14.95% | -33.36% | -2.94% | -25.57% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.